Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028090 · ClinicalTrials.gov registry record
Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of the Sherlock 3CG™ Tip Confirmation System
A clinical trial, sponsored by C. R. Bard.
- Completed
- Registry status
- 182
- Enrollment target
NCT03028090: Completed study, sponsored by C. R. Bard.
NCT03028090 is a clinical trial that has completed, run by C. R. Bard. The registered enrollment target is 182 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03028090 has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- 182 participants
- Enrollment target
Study Summary
This study was to gather real-time ECG data through the use of the SHERLOCK 3CG™ Tip Confirmation System (TCS), an electrocardiogram (ECG)-based peripherally-inserted central catheter (PICC) tip confirmation technology. The study was to promote the development of a software package (MODUS) that can accurately define the maximum P-wave on an ECG waveform. All study participants received PICCs as their standard of care.
Primary Outcome
The measurement used will be percent agreement between clinician and MODUS software. Agreement of 95% between the nurse clinician and software assessments will be used to validate the study hypothesis.
Interventions
- DEVICE SHERLOCK 3CG™ Tip Confirmation System with MODUS Software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-11 |
What the finished NCT03028090 record still lists
NCT03028090 is an observational study that tracks outcomes without assigning an intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which SHERLOCK 3CG™ Tip Confirmation System with MODUS Software is the first listed.
NCT03028090 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03028090 about?
NCT03028090 is a clinical study titled "Study to Assess Electrocardiogram Waveforms Produced Through the Utilization of the Sherlock 3CG™ Tip Confirmation System". This study was to gather real-time ECG data through the use of the SHERLOCK 3CG™ Tip Confirmation System (TCS), an electrocardiogram (ECG)-based peripherally-inserted central catheter (PICC) tip confirmation technology. The study was to promote the development of a software package (MODUS) that can ...
What is the current status of trial NCT03028090?
This trial is currently completed. The enrollment target is 182 participants. The study started on 2013-11. Estimated completion is 2014-11.
What interventions are being tested in trial NCT03028090?
The interventions under investigation include: SHERLOCK 3CG™ Tip Confirmation System with MODUS Software (DEVICE).
Who is sponsoring clinical trial NCT03028090?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia